Advertisement
Advertisement
ICU
SeaStar Medical Holding Corporation Common Stock
4.49
USDSponsored
-0.37
-7.61%
May 08, 15:59 UTC -4
Closed
After-Market
4.62
+0.13
+2.90%
ICU Earnings Reports
Positive Surprise Ratio
ICU beat 6 of 11 last estimates.
55%
Next Report
In 2 Days
Date of Next Report
May 12, 2026
Estimate for Q1 26 (Revenue/ EPS)
$441.88K
/-$0.83
Implied change from Q4 25 (Revenue/ EPS)
+5.21%
/+3.75%
Implied change from Q1 25 (Revenue/ EPS)
+50.81%
/-81.14%
SeaStar Medical Holding Corporation Common Stock earnings per share and revenue
On Mar 25, 2026, ICU reported earnings of -0.80 USD per share (EPS) for Q4 25, beating the estimate of -1.07 USD, resulting in a 25.28% surprise. Revenue reached 420.00 thousand, compared to an expected 376.23 thousand, with a 11.64% difference. The market reacted with a +22.37% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 2 analysts forecast an EPS of -0.83 USD, with revenue projected to reach 441.88 thousand USD, implying an increase of 3.75% EPS, and increase of 5.21% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Natera, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.54
Actual
-$0.56
Surprise
-2.36%
Viatris Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.51
Actual
$0.59
Surprise
+15.17%
Charles River Laboratories International, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.96
Actual
$2.06
Surprise
+4.98%
Caris Life Sciences, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
$0.00
Surprise
+100.00%
Concentra Group Holdings Parent, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.34
Actual
$0.40
Surprise
+17.03%
Establishment Labs Holdings Inc.
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.35
Actual
-$0.40
Surprise
-12.80%
Progyny, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.30
Actual
$0.50
Surprise
+63.99%
Omada Health, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
$0.01
Surprise
+112.22%
The Oncology Institute, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.02
Surprise
+74.46%
LifeMD, Inc. Common Stock
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.20
Surprise
+12.85%
FAQ
What were SeaStar Medical Holding Corporation Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, SeaStar Medical Holding Corporation Common Stock reported EPS of -$0.80, beating estimates by 25.28%, and revenue of $420.00K, 11.64% above expectations.
How did the market react to SeaStar Medical Holding Corporation Common Stock's Q4 2025 earnings?
The stock price moved up 22.37%, changed from $2.28 before the earnings release to $2.79 the day after.
When is SeaStar Medical Holding Corporation Common Stock expected to report next?
The next earning report is scheduled for May 12, 2026.
What are the forecasts for SeaStar Medical Holding Corporation Common Stock's next earnings report?
Based on 2
analysts, SeaStar Medical Holding Corporation Common Stock is expected to report EPS of -$0.83 and revenue of $441.88K for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement